<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9606526</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21796</journal-id>
<journal-id journal-id-type="nlm-ta">Neuropathology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropathology</journal-id>
<journal-title-group>
<journal-title>Neuropathology : official journal of the Japanese Society of Neuropathology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0919-6544</issn>
<issn pub-type="epub">1440-1789</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26381727</article-id>
<article-id pub-id-type="pmc">5458727</article-id>
<article-id pub-id-type="doi">10.1111/neup.12242</article-id>
<article-id pub-id-type="manuscript">NIHMS718376</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>ACTIVATION OF EXTRACELLULAR REGULATED KINASE AND MECHANISTIC TARGET OF RAPAMYCIN PATHWAY IN FOCAL CORTICAL DYSPLASIA</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Patil</surname>
<given-names>Vinit V.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A8">8</xref>
<xref ref-type="aff" rid="A9">9</xref>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guzman</surname>
<given-names>Miguel</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carter</surname>
<given-names>Angela N.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A8">8</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rathore</surname>
<given-names>Geetanjali</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoshor</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Curry</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilfong</surname>
<given-names>Angus</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Agadi</surname>
<given-names>Satish</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Swann</surname>
<given-names>John W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A8">8</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adesina</surname>
<given-names>Adekunle M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhattacharjee</surname>
<given-names>Meenakshi B.</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderson</surname>
<given-names>Anne E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A8">8</xref>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Program in Translational Biology and Molecular Medicine at Baylor College of Medicine, Houston, Texas, USA</aff>
<aff id="A2"><label>2</label>Department of Neurology at Baylor College of Medicine, Houston, Texas, USA</aff>
<aff id="A3"><label>3</label>Department of Pathology at Baylor College of Medicine, Houston, Texas, USA</aff>
<aff id="A4"><label>4</label>Department of Neurosurgery at Baylor College of Medicine, Houston, Texas, USA</aff>
<aff id="A5"><label>5</label>Department of Neuroscience at Baylor College of Medicine, Houston, Texas, USA</aff>
<aff id="A6"><label>6</label>Department of Pediatrics at Baylor College of Medicine, Houston, Texas, USA</aff>
<aff id="A7"><label>7</label>Department of Pathology and Laboratory Medicine, University of Texas Medical School, Houston, Texas, USA</aff>
<aff id="A8"><label>8</label>Cain Foundation Laboratories at Texas Children’s Hospital, Houston, Texas, USA</aff>
<aff id="A9"><label>9</label>Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, Texas, USA</aff>
<aff id="A10"><label>10</label>Department of Pathology, Saint Louis University, Saint Louis, Missouri</aff>
<author-notes>
<corresp id="FN1">Corresponding author: Dr. Anne Anderson, Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, 1250 Moursund Street, Suite 1225, Houston, Texas 77030, Telephone: 832-824-3976, Fax: 832-825-1248, <email>annea@bcm.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>36</volume>
<issue>2</issue>
<fpage>146</fpage>
<lpage>156</lpage>
<!--elocation-id from pubmed: 10.1111/neup.12242-->
<abstract>
<p id="P1">Neuropathology of resected brain tissue has revealed an association of focal cortical dysplasia (FCD) with drug resistant epilepsy (DRE). Recent studies have shown that the mechanistic target of rapamycin (mTOR) pathway is hyperactivated in FCD as evidenced by increased phosphorylation of the ribosomal protein S6 (S6) at serine 240/244 (S<sup>240/244</sup>), a downstream target of mTOR. Moreover, extracellular regulated kinase (ERK) has been shown to phosphorylate S6 at serine 235/236 (S<sup>235/236</sup>) and tuberous sclerosis complex 2 (TSC2) at serine 664 (S<sup>664</sup>) leading to hyperactive mTOR signaling. We evaluated ERK phosphorylation of S6 and TSC2 in two types of FCD (FCD I and FCDII) as a candidate mechanism contributing to mTOR pathway dysregulation in this disorder. Tissue samples from patients with tuberous sclerosis (TS) served as a positive control. Immunostaining for phospho-S6 (pS6<sup>240/244</sup> and pS6<sup>235/236</sup>), phospho-ERK (pERK), and phospho-TSC2 (pTSC2) was performed on resected brain tissue with FCD and TS. We found increased pS6<sup>240/244</sup> and pS6<sup>235/236</sup> staining in FCD I, FCD II, and TS compared to normal appearing tissue, while pERK and pTSC2 staining was increased only in FCD IIb and TS tissue. Our results suggest that both the ERK and mTOR pathways are dysregulated in FCD and TS; however, the signaling alterations are different for FCD I as compared to FCD II and TS.</p>
</abstract>
<kwd-group>
<kwd>focal cortical dysplasia (FCD)</kwd>
<kwd>tuberous sclerosis (TS)</kwd>
<kwd>drug resistant epilepsy (DRE)</kwd>
<kwd>mechanistic target of rapamycin (mTOR)</kwd>
<kwd>extracellular-regulated kinase (ERK)</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>